Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Annals of the New York Academy of Sciences|January 20, 1975
The therapeutic role of epsilon-aminocaproic acid (EACA) for dental extractions in hemophiliacsP N Walsh, C R Rizza, B E Evans, et al.
Transfusion|April 1, 1995
Comparison of the recovery and half-life of a high-purity factor IX concentrate with those of a factor IX complex concentrate. Factor IX Study GroupM C Poon, L M Aledort, K Anderle, et al.
British Journal of Haematology|October 1, 1990
Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodiesA M Aly, L M Aledort, T D Lee, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 21, 2013
Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrateJ Oldenburg, V Jiménez-Yuste, R Peiró-Jordán, et al.
Transfusion|May 21, 1999
Anti-G in a pregnant patientK Cash, T Brown, A Strupp, et al.
Blood|July 1, 1988
A second BamHI DNA polymorphism and haplotype association in the factor IX geneM C Driscoll, A Dispenzieri, E Tobias, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart reviewE H Kraut, L M Aledort, S Arkin, et al.
Blood|July 15, 1995
A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulinR S Schwartz, D A Gabriel, L M Aledort, et al.
Clinical Orthopaedics and Related Research|July 1, 1996
Long term evaluation of septic arthritis in hemophilic patientsM S Gilbert, L M Aledort, S Seremetis, et al.
Blood|May 1, 1991
Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effectJ B Bussel, J N Graziano, R P Kimberly, et al.
Pageof 11